The gold standard treatment for non-metastatic upper tract urothelial cancer (UTUC) is represented by radical nephroureterectomy (RNU). The choice of surgical technique in performing UTUC surgery continues to depend on several factors, including the location and extent of the tumor, the patient’s overall health, and very importantly, the surgeon’s skill, experience, and preference. Although open and laparoscopic approaches are well-established treatments, evidence regarding robot-assisted radical nephroureterectomy (RANU) is growing. Aim of our study was to perform a critical review on the evidence of the last 5 years regarding surgical techniques and outcomes of minimally invasive RNU, mostly focusing on RANU. Reported oncological and function outcomes suggest that minimally invasive RNU is safe and effective, showing similar survival rates compared to the open approach.
对于非转移性上尿路尿路上皮癌(UTUC)的标准治疗方法是根治性肾输尿管切除术(RNU)。UTUC手术中手术技术的选择仍取决于多种因素,包括肿瘤的位置和范围、患者的整体健康状况,以及非常重要的外科医生的技能、经验和偏好。尽管开放手术和腹腔镜手术是成熟的治疗方法,但关于机器人辅助根治性肾输尿管切除术(RANU)的证据正在不断增加。本研究旨在对过去五年中关于微创RNU(主要聚焦于RANU)的手术技术和结果证据进行批判性综述。报告的肿瘤学和功能结果表明,微创RNU是安全有效的,与开放手术相比显示出相似的生存率。
Minimally Invasive Radical Nephroureterectomy: 5-Year Update of Techniques and Outcomes